InvestorsObserver
×
News Home

Is Lexicon Pharmaceuticals Inc (LXRX) Stock a Bad Value Wednesday?

Wednesday, March 27, 2024 10:59 AM | InvestorsObserver Analysts

Mentioned in this article

Is Lexicon Pharmaceuticals Inc (LXRX) Stock a Bad Value Wednesday?

Lexicon Pharmaceuticals Inc (LXRX) is around the top of the Healthcare sector according to InvestorsObserver. LXRX received an overall rating of 49, which means that it scores higher than 49% of stocks. Additionally, Lexicon Pharmaceuticals Inc scored a 78 in the Healthcare sector, ranking it higher than 78% of stocks in that sector.

Overall Score - 49
LXRX has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on LXRX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 49 means the stock is more attractive than 49 percent of stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Lexicon Pharmaceuticals Inc Stock Today?

Lexicon Pharmaceuticals Inc (LXRX) stock is trading at $2.24 as of 10:52 AM on Wednesday, Mar 27, a rise of $0.26, or 13.09% from the previous closing price of $1.98. The stock has traded between $1.99 and $2.29 so far today. Volume today is below average. So far 2,997,308 shares have traded compared to average volume of 5,755,446 shares. Click Here to get the full Stock Report for Lexicon Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App